Agena Improves PGx Testing Accuracy with Launch of VeriDose™ CYP2D6 CNV Panel

Agena Improves PGx Testing Accuracy with Launch of VeriDose™ CYP2D6 CNV Panel Quantification of Hybrid Alleles Not Detected by Common PGx Technologies San Diego, CA, November 4, 2019– Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the VeriDose™ CYP2D6 CNV panel designed to... Read More

Agena Launches Bone Marrow Engraftment Assay For Chimerism Analysis

San Diego, CA, November 1, 2018 – Agena Bioscience, a global provider of molecular testing solutions, today announced the release of the Chimeric ID Panel designed to reduce the time and cost of performing chimerism analysis for bone marrow engraftment monitoring studies. The SNP-based panel is designed for research... Read More

Agena Bioscience Announces Collaboration with PerkinElmer

Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced today that they have entered into a collaboration with PerkinElmer, incorporating the LabChip® GX Touch™ nucleic acid analyzer for quality assessment and quantitation of DNA in the... Read More
Showing: 1–10 of 40